401 related articles for article (PubMed ID: 15304571)
1. Genetically modified adenoviruses against gliomas: from bench to bedside.
Gomez-Manzano C; Yung WK; Alemany R; Fueyo J
Neurology; 2004 Aug; 63(3):418-26. PubMed ID: 15304571
[TBL] [Abstract][Full Text] [Related]
2. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.
Jiang H; Gomez-Manzano C; Alemany R; Medrano D; Alonso M; Bekele BN; Lin E; Conrad CC; Yung WK; Fueyo J
Neoplasia; 2005 Jan; 7(1):48-56. PubMed ID: 15720816
[TBL] [Abstract][Full Text] [Related]
3. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.
Shinoura N; Yoshida Y; Tsunoda R; Ohashi M; Zhang W; Asai A; Kirino T; Hamada H
Cancer Res; 1999 Jul; 59(14):3411-6. PubMed ID: 10416603
[TBL] [Abstract][Full Text] [Related]
4. Control of p53 expression by adenovirus 12 early region 1A and early region 1B 54K proteins.
Grand RJ; Owen D; Rookes SM; Gallimore PH
Virology; 1996 Apr; 218(1):23-34. PubMed ID: 8615026
[TBL] [Abstract][Full Text] [Related]
5. A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.
Gomez-Manzano C; Balague C; Alemany R; Lemoine MG; Mitlianga P; Jiang H; Khan A; Alonso M; Lang FF; Conrad CA; Liu TJ; Bekele BN; Yung WK; Fueyo J
Oncogene; 2004 Mar; 23(10):1821-8. PubMed ID: 15014451
[TBL] [Abstract][Full Text] [Related]
6. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
7. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
Savelyeva I; Dobbelstein M
Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
[TBL] [Abstract][Full Text] [Related]
8. Selective effects of E1B-defective adenoviruses and adenovirus E1A mutants in deficient mouse primary embryonic fibroblasts.
Martin Duque P; Parada C; Guinea J; Sanchez-Prieto R; Ramon Y Cajal S
Int J Oncol; 2001 Jun; 18(6):1163-7. PubMed ID: 11351246
[TBL] [Abstract][Full Text] [Related]
9. New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication.
Hernandez-Alcoceba R; Pihalja M; Qian D; Clarke MF
Hum Gene Ther; 2002 Sep; 13(14):1737-50. PubMed ID: 12396626
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.
Vera B; Martínez-Vélez N; Xipell E; Acanda de la Rocha A; Patiño-García A; Saez-Castresana J; Gonzalez-Huarriz M; Cascallo M; Alemany R; Alonso MM
PLoS One; 2016; 11(1):e0147211. PubMed ID: 26808201
[TBL] [Abstract][Full Text] [Related]
11. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
12. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
[TBL] [Abstract][Full Text] [Related]
13. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
14. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection.
Goodrum FD; Ornelles DA
J Virol; 1998 Dec; 72(12):9479-90. PubMed ID: 9811681
[TBL] [Abstract][Full Text] [Related]
15. Lack of evidence of phenotypic complementation of E1A/E1B-deleted adenovirus type 5 upon superinfection by wild-type virus in the cotton rat.
Oualikene W; Gonin P; Eloit M
J Virol; 1995 Oct; 69(10):6518-24. PubMed ID: 7666553
[TBL] [Abstract][Full Text] [Related]
16. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
Rao XM; Tseng MT; Zheng X; Dong Y; Jamshidi-Parsian A; Thompson TC; Brenner MK; McMasters KM; Zhou HS
Cancer Gene Ther; 2004 Sep; 11(9):585-93. PubMed ID: 15338010
[TBL] [Abstract][Full Text] [Related]
17. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.
Spitkovsky D; Steiner P; Gopalkrishnan RV; Eilers M; Jansen-Dürr P
Oncogene; 1995 Jun; 10(12):2421-5. PubMed ID: 7784093
[TBL] [Abstract][Full Text] [Related]
18. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
19. E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.
Hobom U; Dobbelstein M
J Virol; 2004 Jul; 78(14):7685-97. PubMed ID: 15220443
[TBL] [Abstract][Full Text] [Related]
20. Modification of the Rb-binding domain of replication-competent adenoviral vector enhances cytotoxicity against human esophageal cancers via NF-kappaB activity.
Yamada K; Moriyama H; Yasuda H; Hara K; Maniwa Y; Hamada H; Yokono K; Nagata M
Hum Gene Ther; 2007 May; 18(5):389-400. PubMed ID: 17518613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]